These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3138955)

  • 1. [Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcoma immunomodulatory effect of interferons on tumor-associated antigen].
    Miyatake S
    Nihon Geka Hokan; 1988 Jan; 57(1):55-68. PubMed ID: 3138955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunomodulatory effects of interferons on target human gliosarcoma cells in the tumor-specific CTL- and LAK-mediated cytolysis].
    Miyatake S; Kondou S; Aoki T; Iwasaki K; Ohyama K; Ootsuka S; Oda Y; Kikuchi H
    No Shinkei Geka; 1991 Nov; 19(11):1053-9. PubMed ID: 1762655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse gamma-interferon complementary DNA.
    Nishihara K; Miyatake S; Sakata T; Yamashita J; Kikuchi H; Kawade Y; Zu Y; Namba Y; Hanaoka M; Watanabe Y
    Cancer Res; 1988 Sep; 48(17):4730-5. PubMed ID: 3136912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon: a cytotoxic T lymphocyte differentiation signal.
    Chen LK; Tourvieille B; Burns GF; Bach FH; Mathieu-Mahul D; Sasportes M; Bensussan A
    Eur J Immunol; 1986 Jul; 16(7):767-70. PubMed ID: 3087758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of experimental malignant glioma-specific cytotoxic T lymphocyte clone by T cell growth factor.
    Yamasaki T; Handa H; Yamashita J; Namba Y; Watanabe Y; Kuwata S; Hanaoka M
    J Neurosurg; 1984 May; 60(5):998-1004. PubMed ID: 6201598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcoma.
    Miyatake S; Kikuchi H; Iwasaki K; Yamashita J; Li ZY; Namba Y; Hanaoka M
    J Neurosurg; 1988 Nov; 69(5):751-9. PubMed ID: 3263476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular immunotherapy for malignant glioma].
    Okamoto Y; Yamashita J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoregulatory role in gamma interferon production by a T cell growth factor-dependent experimental malignant glioma-specific cytotoxic T lymphocyte clone.
    Yamasaki T; Handa H; Yamashita J; Watanabe Y; Taguchi M; Kuwata S; Namba Y; Hanaoka M
    J Neurosurg; 1985 Nov; 63(5):763-70. PubMed ID: 3932609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
    Slovin SF; Lackman RD; Ferrone S; Kiely PE; Mastrangelo MJ
    J Immunol; 1986 Nov; 137(9):3042-8. PubMed ID: 3093588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.
    Ginzkey C; Eicker SO; Marget M; Krause J; Brecht S; Westphal M; Hugo HH; Mehdorn HM; Steinmann J; Hamel W
    Cancer Immunol Immunother; 2010 Apr; 59(4):541-51. PubMed ID: 19798500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
    Yamasaki T; Yamashita J; Handa H; Namda Y; Hanaoka M
    No Shinkei Geka; 1983 Oct; 11(10):1059-67. PubMed ID: 6196674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface antigens of human glioma cells shared with normal adult and fetal brain.
    Wikstrand CJ; Bigner DD
    Cancer Res; 1979 Aug; 39(8):3235-43. PubMed ID: 88260
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
    Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
    J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma.
    Kobayashi T; Yamanaka R; Homma J; Tsuchiya N; Yajima N; Yoshida S; Tanaka R
    Cancer Immunol Immunother; 2003 Oct; 52(10):632-7. PubMed ID: 12827308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasma gondii-specific CD4+ T cell clones from healthy, latently infected humans display a Th0 profile of cytokine secretion.
    Prigione I; Facchetti P; Ghiotto F; Tasso P; Pistoia V
    Eur J Immunol; 1995 May; 25(5):1298-305. PubMed ID: 7774633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y; Bigner DD
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.